RECORDATI RARE FDA Approval NDA 018878

NDA 018878

RECORDATI RARE

FDA Drug Application

Application #018878

Documents

Letter2003-05-30
Letter2007-01-25
Label2007-01-16
Letter2003-05-30
Letter2006-02-08
Letter2010-01-26
Label2006-02-07
Label2010-01-20
Label2021-03-29
Letter2021-03-30

Application Sponsors

NDA 018878RECORDATI RARE

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 1MG BASE/VIAL1INDOCININDOMETHACIN SODIUM

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1985-01-30PRIORITY
LABELING; LabelingSUPPL2AP1985-06-20
LABELING; LabelingSUPPL5AP1988-06-08
LABELING; LabelingSUPPL10AP1994-09-21
LABELING; LabelingSUPPL11AP1994-09-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1997-10-14PRIORITY
LABELING; LabelingSUPPL14AP1998-05-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2000-10-24PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2000-11-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2001-02-12PRIORITY
LABELING; LabelingSUPPL18AP2003-05-06STANDARD
LABELING; LabelingSUPPL19AP2003-05-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2002-11-08PRIORITY
LABELING; LabelingSUPPL23AP2006-02-01STANDARD
LABELING; LabelingSUPPL24AP2007-01-12STANDARD
LABELING; LabelingSUPPL27AP2010-01-19UNKNOWN
LABELING; LabelingSUPPL29AP2021-03-26STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL13Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL20Null0
SUPPL27Null6
SUPPL29Null15

TE Codes

001PrescriptionAP

CDER Filings

RECORDATI RARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18878
            [companyName] => RECORDATI RARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"INDOCIN","activeIngredients":"INDOMETHACIN SODIUM","strength":"EQ 1MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"01\/19\/2010","submission":"SUPPL-27","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/018878s027lbl.pdf\"}]","notes":""},{"actionDate":"01\/12\/2007","submission":"SUPPL-24","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/018878s024lbl.pdf\"}]","notes":""},{"actionDate":"02\/01\/2006","submission":"SUPPL-23","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/018878s023lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"INDOCIN","submission":"INDOMETHACIN SODIUM","actionType":"EQ 1MG BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2010-01-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.